FIELD: medicine.
SUBSTANCE: described is stable pharmaceutical preparation of absorption type for transcutaneous introduction, which includes bottom layer and adhesive layer, containing metal chloride, adhesive and at least one composition from (-)-(R)-N, α-dimethyl-N-2-propinylphenethylamine and its hydrochloride, where adhesive layer is subjected to crosslinking.
EFFECT: pharmaceutical preparation of absorption type for transcutaneous introduction of selegiline or selegiline hydrochloride does not suffer reduction of cohesive strength of adhesive layer even in presence of sweat components caused by excretion of sweat during wearing, and is free of cohesive destruction and remains of adhesive when preparation is removed.
4 cl, 2 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
ABSORPTION PHARMACEUTICAL PREPARATION FOR PERCUTANEOUS INTRODUCTION | 2006 |
|
RU2432179C2 |
COMPOSITION FOR TRANSCUTANEOUS ABSORPTION | 2007 |
|
RU2435570C2 |
ADHESIVE COMPOUND CONTAINING SELEGILIN | 2011 |
|
RU2561043C2 |
ADHESIVE COMPOUND CONTAINING SELEGILIN | 2011 |
|
RU2561044C2 |
ADHESIVE COMPOUND CONTAINING SELEGILIN | 2011 |
|
RU2561042C2 |
NICOTINE TRANSDERMAL DELIVERY SYSTEM | 2006 |
|
RU2400216C2 |
DONEPEZIL-CONTAINING ADHESIVE MEDICATION AND PACKAGE FOR IT | 2009 |
|
RU2481826C2 |
ADHESIVE PHARMACEUTICAL BISOPROPOL-CONTAINING COMPOSITION | 2006 |
|
RU2396951C2 |
METHOD FOR STAINING INHIBITION OF DONEPEZIL-CONTAINING ADHESIVE COMPOSITION AND METHOD FOR REDUCTION OF FORMED DONEPEZIL-RELATED COMPOUNDS | 2007 |
|
RU2460520C2 |
METHOD FOR TIME FADING INHIBITION OF DONEPEZIL-CONTAINING ADHESIVE COMPOSITION | 2007 |
|
RU2460521C2 |
Authors
Dates
2010-08-20—Published
2006-06-05—Filed